UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cells

Leukemia & lymphoma, 2019-01, Vol.60 (1), p.189-199

2019

Link zum Volltext

Verfügbarkeit prüfen

MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR–ABL protein

Cancer letters, 2015-01, Vol.356 (2), p.597-605

2015

Link zum Volltext

Verfügbarkeit prüfen

Restoration of miR-424 suppresses BCR–ABL activity and sensitizes CML cells to imatinib treatment

Cancer letters, 2015-05, Vol.360 (2), p.245-256

2015

Link zum Volltext

Verfügbarkeit prüfen

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells

PloS one, 2012-04, Vol.7 (4), p.e35501-e35501

2012

Link zum Volltext

Verfügbarkeit prüfen

P657: PATHOGENESIS OF TYROSINE KINASE INHIBITOR–ASSOCIATED VASCULAR TOXICITY IN CHRONIC MYELOID LEUKEMIA

HemaSphere, 2023-08, Vol.7 (S3), p.e95758de-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Neutrophil Extracellular Traps Are Increased in Chronic Myeloid Leukemia and Are Differentially Affected by Tyrosine Kinase Inhibitors

Cancers, 2021-12, Vol.14 (1), p.119

2021

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphoma

Leukemia & lymphoma, 2013-04, Vol.54 (4), p.851-859

2013

Link zum Volltext

Verfügbarkeit prüfen

Using the Iron Chelator Deferasirox to Overcome Drug Resistance in Mantle Cell Lymphoma

Blood, 2021-11, Vol.138 (Supplement 1), p.4364-4364

2021

Link zum Volltext

Verfügbarkeit prüfen

Using NK-Derived Exosomes to Treat Leukemia

Blood, 2021-11, Vol.138 (Supplement 1), p.1872-1872

2021

Link zum Volltext

Verfügbarkeit prüfen

Nonmuscle Myosin Heavy Chain IIA Mutations Define a Spectrum of Autosomal Dominant Macrothrombocytopenias: May-Hegglin Anomaly and Fechtner, Sebastian, Epstein, and Alport-Like Syndromes

American journal of human genetics, 2001-11, Vol.69 (5), p.1033-1045

2001

Link zum Volltext

Verfügbarkeit prüfen

The Anti-Leukemia Effect of Natural Killer-Derived Exosomes

Blood, 2019-11, Vol.134 (Supplement_1), p.4652-4652

2019

Link zum Volltext

Verfügbarkeit prüfen

Deferasirox induces cyclin D1 degradation and apoptosis in mantle cell lymphoma in a reactive oxygen species‐ and GSK3β‐dependent mechanism

British journal of haematology, 2021-02, Vol.192 (4), p.747-760

2021

Link zum Volltext

Verfügbarkeit prüfen

Extracorporeal Photopheresis Induces Netosis in Neutrophils Derived from Patients with Graft-Versus-Host Disease

Blood, 2021-11, Vol.138 (Supplement 1), p.4873-4873

2021

Link zum Volltext

Verfügbarkeit prüfen

BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma

Blood, 2006-02, Vol.107 (4), p.1599-1607

2006

Link zum Volltext

Verfügbarkeit prüfen

Using natural killer cell‐derived exosomes as a cell‐free therapy for leukemia

Hematological oncology, 2023-08, Vol.41 (3), p.487-498

2023

Link zum Volltext

Verfügbarkeit prüfen

Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34+CD38– cells through iron chelation, induction of ROS, and inhibition of HIF1α expression

Experimental hematology, 2019-02, Vol.70, p.55-69.e4

2019

Link zum Volltext

Verfügbarkeit prüfen

A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1

Oncogene, 2002-02, Vol.21 (10), p.1469-1476

2002

Link zum Volltext

Verfügbarkeit prüfen

Profiling and bioinformatics analyses reveal chronic lymphocytic leukemia cells share a unique circular RNA expression pattern

Experimental hematology, 2020-05, Vol.85, p.8-12

2020

Link zum Volltext

Verfügbarkeit prüfen

Poster: MCL-101: Using the Iron Chelator Deferasirox to Overcome Drug Resistance in Mantle Cell Lymphoma

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S247-S247

2021

Link zum Volltext

Verfügbarkeit prüfen

MCL-101: Using the Iron Chelator Deferasirox to Overcome Drug Resistance in Mantle Cell Lymphoma

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S408-S409

2021

Link zum Volltext

Verfügbarkeit prüfen

Poster: CML-074 Pathogenesis of Tyrosine Kinase Inhibitor–Associated Vascular Toxicity in Chronic Myeloid Leukemia

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S147

2022

Link zum Volltext

Verfügbarkeit prüfen

CML-074 Pathogenesis of Tyrosine Kinase Inhibitor–Associated Vascular Toxicity in Chronic Myeloid Leukemia

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S286-S287

2022

Link zum Volltext

Verfügbarkeit prüfen

Is cure of chronic myeloid leukemia in the third millennium a down to earth target (ed) or a castle in the air?

Cancer letters, 2014-09, Vol.352 (1), p.21-27

2014

Link zum Volltext

Verfügbarkeit prüfen

Dasatinib induces endothelial dysfunction leading to impaired recovery from ischaemia

British journal of haematology, 2024-06

2024

Link zum Volltext

Verfügbarkeit prüfen

Ponatinib reduces viability, migration, and functionality of human endothelial cells

Leukemia & lymphoma, 2017-06, Vol.58 (6), p.1455-1467

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(80)
Buchkapitel
(1)

Sprache

Englisch
(81)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(39)
Humans
(30)
Hematology
(18)
Oncology
(14)
Apoptosis
(10)
Biological And Medical Sciences
(9)
Female
(8)
Hematology, Oncology And Palliative Medicine
(8)
Male
(8)
Kinases
(7)
Leukemia
(7)
Medical Sciences
(7)
Antineoplastic Agents - Pharmacology
(6)
Base Sequence
(6)
Cardiac & Cardiovascular Systems
(6)
Cardiovascular System & Cardiology
(6)
Cml
(6)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Genetics
(6)
Cancer Research
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cells

MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR–ABL protein

Restoration of miR-424 suppresses BCR–ABL activity and sensitizes CML cells to imatinib treatment

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells

P657: PATHOGENESIS OF TYROSINE KINASE INHIBITOR–ASSOCIATED VASCULAR TOXICITY IN CHRONIC MYELOID LEUKEMIA

Neutrophil Extracellular Traps Are Increased in Chronic Myeloid Leukemia and Are Differentially Affected by Tyrosine Kinase Inhibitors

Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphoma

Using the Iron Chelator Deferasirox to Overcome Drug Resistance in Mantle Cell Lymphoma

Using NK-Derived Exosomes to Treat Leukemia

Nonmuscle Myosin Heavy Chain IIA Mutations Define a Spectrum of Autosomal Dominant Macrothrombocytopenias: May-Hegglin Anomaly and Fechtner, Sebastian, Epstein, and Alport-Like Syndromes

The Anti-Leukemia Effect of Natural Killer-Derived Exosomes

Deferasirox induces cyclin D1 degradation and apoptosis in mantle cell lymphoma in a reactive oxygen species‐ and GSK3β‐dependent mechanism

Extracorporeal Photopheresis Induces Netosis in Neutrophils Derived from Patients with Graft-Versus-Host Disease

BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma

Using natural killer cell‐derived exosomes as a cell‐free therapy for leukemia

Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34+CD38– cells through iron chelation, induction of ROS, and inhibition of HIF1α expression

A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1

Profiling and bioinformatics analyses reveal chronic lymphocytic leukemia cells share a unique circular RNA expression pattern

Poster: MCL-101: Using the Iron Chelator Deferasirox to Overcome Drug Resistance in Mantle Cell Lymphoma

MCL-101: Using the Iron Chelator Deferasirox to Overcome Drug Resistance in Mantle Cell Lymphoma

Poster: CML-074 Pathogenesis of Tyrosine Kinase Inhibitor–Associated Vascular Toxicity in Chronic Myeloid Leukemia

CML-074 Pathogenesis of Tyrosine Kinase Inhibitor–Associated Vascular Toxicity in Chronic Myeloid Leukemia

Is cure of chronic myeloid leukemia in the third millennium a down to earth target (ed) or a castle in the air?

Dasatinib induces endothelial dysfunction leading to impaired recovery from ischaemia

Ponatinib reduces viability, migration, and functionality of human endothelial cells

Suchergebnisse filtern